MediPoint: Electrophysiology - Global Analysis and Market Forecasts - Tucson News Now

MediPoint: Electrophysiology - Global Analysis and Market Forecasts

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE ReportBuyer

LONDON, April 28, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:

MediPoint: Electrophysiology - Global Analysis and Market Forecasts

http://www.reportbuyer.com/pharma_healthcare/medical_devices/medipoint_electrophysiology_global_analysis_market_forecasts.html

MediPoint: Electrophysiology - Global Analysis and Market Forecasts

Summary

Still in its infancy, the electrophysiology (EP) device market has seen significant adoption and market growth as more physicians become experienced in diagnostic and ablation techniques, increasing numbers of hospitals purchase supportive equipment, device prices fall, and efficacy improves. This continued growth is also driven by technological advancements, including the emergence of next-generation ablation technologies, improvements in catheter diagnostics, and advancements in lab systems. Further, as imaging modalities improve, patients are exposed to less radiation than ever before, which will only further drive diagnostics. Still years behind the US, growth in emerging markets is also expected to drive sales, as developing countries look to implement new EP programs and hospitals adopt ablation techniques. Increases in the prevalence of arrhythmia, combined with improved diagnostics and patient awareness, are expected to support industry expansion. Lastly, published studies, clinical evidence and patient awareness will all contribute positively to EP market growth, and will provide further evidence of the effectiveness of catheter ablation.

The EP market is dominated by several key players, including Biosense Webster, St. Jude Medical, Boston Scientific, Medtronic and Biotronik, with the biggest markets in the US and EU. With improvements in reimbursement worldwide, as well as advancements of global distribution channels, devices are being sold in more hospitals than ever, and this is only expected to increase. With only a few key players in the market currently, competition remains high, as industry leaders fight for valuable market share.

GlobalData has released its medical device report, Electrophysiology – Global Analysis and Market Forecasts. The report offers a comprehensive analysis of the global EP market, including development and sales of ablation catheters, diagnostic catheters and lab systems in the US, Germany, Italy, Spain, UK, France, China, India, Japan and Brazil. Included within is an examination of the drivers, opportunities and barriers impacting growth of the EP market worldwide, with an in-depth breakdown of the EP market seven-year global forecast. The report identifies and evaluates key trends and unmet needs shaping the global EP market through 2020, highlighting testimonials from top physicians around the world who are utilizing these devices. Future sales expectations are discussed through careful analysis of EP use adoption patterns in the ten major markets. The report provides insight into the competitive EP landscape, including new companies approaching commercialization and pipeline products in development. It quantifies the potential of rising use of advanced ablation and diagnostic catheters, as well as examines the impact of next-generation mapping and navigation technology on patient outcomes. Included in the report is investigation of the highest growth sectors for EP, with a focus on next-generation technologies due to enter the market, including laser energy and three-dimensional mapping technology. This report was built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of cardiovascular medical device experts.

Highlights

Key Questions Answered

- Improvements in EP device technology are evident in improved patient outcomes. (Q). How have clinical trials touting patient benefits shaped the EP device landscape? (Q). How will they affect adoption?
- Cardiac ablation is increasingly used as a first-line therapy in lieu of AADs. (Q). What is to be expected in terms of regulation and reimbursement around the use of ablation over AADs? (Q). How will AADs be used as adjunctive therapy in the future?
- Technological advancements have enabled next-generation therapy, including irrigated catheters and alternative energy ablation tools. (Q). What technologies will be most popular in the coming years? (Q). What products are positioned to see significant adoption?
- The EP devices market in the developing countries of the Asia-Pacific region as well as South America is expected to experience higher rates of growth compared with the US and EU. (Q). Which countries will have the highest annual growth rate in the EP diagnostic catheter, ablation catheter and lab systems markets?
- As more hospitals look to implement EP operations, lab systems sales are on the rise as a result. (Q). How many hospitals are there in each country, and how many are looking to implement EP? How is this changing during the forecast period?

Key Benefits

"What Do Physicians Think?" quotes provide a unique insight into how healthcare professionals are reacting to events within the industry, and what their responses could mean for industry strategists. This information is essential for all strategic decision-makers in every organization, allowing them to act on high-quality information.

Scope

- An overview of arrhythmia, including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines worldwide
- Annualized global EP device market revenue, future forecasts and procedure patterns data from 2005 and forecast to 2020, including use of standard and advanced diagnostic and ablation catheters, as well as lab systems
- Investigation of current and future market competition for EP devices
- Coverage of ten major markets, including the United States, the United Kingdom, Italy, Spain, Germany, France, Japan, China, India and Brazil
- Insightful review of the key industry drivers, restraints and challenges, as well as predicted impact of future key events
- Competitive assessment with device approval analysis and sales forecasts
- Marketed and pipeline product profiles covering efficacy, safety, clinical study details, regulatory approvals, and forecast device sales
- Analysis of unmet needs within the market and opportunities for future players
- Evaluation of technology trends to assess pipeline product strength
- Overview of all devices in development, including clinical study details, design considerations, efficacy reports, and device approval timelines
- Coverage of key market players with portfolio assessment and SWOT analysis
- Strategic assessment of the device sector through market impact, future market scenario and company analysis
- Direct quotes from Key Opinion Leaders (KOL) currently using EP devices

Reasons to buy

- Understand the trends shaping and driving the ablation catheter, diagnostic catheter and lab system markets
- Realize device preferences of physicians who have performed hundreds of catheter diagnostic and ablation procedures already
- Access market sizing, forecasts and quantified growth opportunities in the global EP market through 2020
- Quantify candidate patient populations worldwide to better design product pricing and launch plans
- Drive revenues, formulate effective sales and marketing strategies, and gain in-depth understanding of the competitive landscape
- Perform benchmarking analysis of growth opportunities against currently marketed products
- Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition
- Take a comprehensive look at the market's device pipeline and identify promising, paradigm-shifting products
- Create an effective counter-strategy to gain a competitive advantage against those currently in the market
- Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for growth
- What's the next big thing in the global EP market landscape? Identify, understand and capitalize
1 Table of Contents
1 Table of Contents 9
1.1 List of Tables 17
1.2 List of Figures 24
2 Introduction 29
2.1 Catalyst 29
2.2 Related Reports 29
3 Industry Overview 30
3.1 Introduction 30
3.2 Anatomy and Physiology 30
3.2.1 Etiology 31
3.2.2 Risk Factors 32
3.2.3 Types of Arrhythmia 33
3.3 Clinical Presentation 36
3.3.1 Symptoms 36
3.4 Diagnosis 37
3.4.1 Blood and Urine Diagnostic Procedures 37
3.4.2 Electrocardiography-Based Diagnostic Procedures 38
3.4.3 Computerized Tomographic Angiography 39
3.4.4 Electrophysiological Testing 39
3.4.5 Electromechanical Wave Imaging 39
3.4.6 Echocardiography 40
3.4.7 Tilt-Taable Testing 40
3.4.8 Diagnostic and Electrophysiological Studies 40
3.4.9 New York Heart Association Scale 40
3.4.10 American College of Cardiology Scale 41
3.5 Epidemiology 42
3.5.1 Prevalence 42
3.6 Market Segmentation 45
3.6.1 Electrophysiology Diagnostic Catheter 45
3.6.2 Electrophysiology Ablation Catheter 46
3.6.3 Electrophysiology Lab Systems 60
3.7 Treatment Costs, Pricing, and Reimbursement 60
3.7.1 Direct Costs 63
3.7.2 Indirect Costs 66
3.7.3 US Costs 68
3.7.4 Pricing of Electrophysiology Devices and Equipment 70
3.7.5 Reimbursement 70
3.8 Market Characterization 81
3.8.1 Growing Patient Population Suitable for Treatment 81
3.8.2 Increasing Prevalence of Arrhythmia with Age 82
3.8.3 Emergence of Remote Catheter Navigation and Ablation Technology 84
3.8.4 Focus on the Development of "Single Shot" Devices 87
3.8.5 Catheter Localization Aided by Novel Mapping and Visualization Techniques 88
3.8.6 Electrophysiology Market Trends in Inorganic Growth through Consolidation 89
3.8.7 Lack of Skilled and Experienced Electrophysiologists to Negatively Impact Procedure Volumes and Hinder Market Growth 89
3.8.8 Awareness and Education to Drive Earlier Intervention 90
3.9 Regulatory Issues and Recalls 91
4 Segment Analysis 92
4.1 Ablation Catheters Market Dynamics 92
4.1.1 Ablation Catheters Market Drivers 92
4.1.2 Ablation Catheters Market Barriers 110
4.2 Diagnostic Catheters Market Dynamics 122
4.2.1 Diagnostic Catheters Market Drivers 122
4.2.2 Diagnostic Catheters Market Barriers 123
4.3 Lab Systems Market Dynamics 126
4.3.1 Lab Systems Market Drivers 126
4.3.2 Lab Systems Market Barriers 128
5 Market Outlooks by Market Segment 130
5.1 Global Ablation Catheters Market 130
5.1.1 Ablation Catheters Market, Global, Historic Revenue ($m), 2005-2013 130
5.1.2 Ablation Catheters Market, Global, Forecast Revenue ($m), 2013-2020 131
5.1.3 Diagnostic Catheters Market, Global, Historic Revenue ($m), 2005-2013 132
5.1.4 Diagnostic Catheters Market, Global, Forecast Revenue ($m), 2013-2020 133
5.1.5 Lab Systems Market, Global, Historic Revenue ($m), 2005-2013 134
5.1.6 Lab Systems Market, Global, Forecast Revenue ($m), 2013-2020 135
6 Market Outlooks by Geography 136
6.1 US 136
6.1.1 Overview 136
6.1.2 Market Analysis 136
6.2 France 145
6.2.1 Overview 145
6.2.2 Market Analysis 148
6.3 Germany 157
6.3.1 Overview 157
6.3.2 Market Analysis 157
6.4 Italy 166
6.4.1 Overview 166
6.4.2 Market Analysis 166
6.5 Spain 175
6.5.1 Overview 175
6.5.2 Market Analysis 178
6.6 UK 188
6.6.1 Overview 188
6.6.2 Market Analysis 189
6.7 Japan 197
6.7.1 Overview 197
6.7.2 Market Analysis 198
6.8 China 206
6.8.1 Overview 206
6.8.2 Market Analysis 207
6.9 India 215
6.9.1 Overview 215
6.9.2 Market Analysis 216
6.10 Brazil 224
6.10.1 Overview 224
6.10.2 Market Analysis 225
6.10.3 Market Analysis 226
7 Strategic Competitive Assessment 235
7.1 Key Company Share 235
7.1.1 Global 235
7.1.2 US 236
7.1.3 France 238
7.1.4 Germany 239
7.1.5 Italy 240
7.1.6 Spain 241
7.1.7 UK 242
7.1.8 Japan 243
7.1.9 China 244
7.1.10 India 245
7.1.11 Brazil 246
8 Current and Future Players 248
8.1 Biosense Webster 248
8.1.1 Overview 248
8.1.2 Portfolio Evaluation 248
8.1.3 Biosense Webster SWOT Analysis 249
8.2 Biotronik 253
8.2.1 Overview 253
8.2.2 Portfolio Evaluation 253
8.2.3 Biotronik SWOT Analysis 254
8.3 Boston Scientific 259
8.3.1 Overview 259
8.3.2 Boston Scientific Acquires Bard EP and Rhythmia Medical 259
8.3.3 Portfolio Evaluation 260
8.3.4 Boston Scientific SWOT Analysis 263
8.4 CardioFocus 269
8.4.1 Overview 269
8.4.2 Portfolio Evaluation 270
8.4.3 Company SWOT Analysis 271
8.5 CardioInsight 274
8.5.1 Overview 274
8.5.2 Portfolio Evaluation 274
8.5.3 CardioInsight SWOT Analysis 275
8.6 Hansen Medical 277
8.6.1 Overview 277
8.6.2 Portfolio Evaluation 278
8.6.3 Company SWOT Analysis 278
8.7 Imricor 281
8.7.1 Overview 281
8.7.2 Portfolio Evaluation 281
8.7.3 Company SWOT Analysis 282
8.8 Japan Lifeline 284
8.8.1 Overview 284
8.8.2 Portfolio Evaluation 285
8.8.3 Company SWOT Analysis 285
8.9 Magnetecs Corporation 288
8.9.1 Overview 288
8.9.2 Portfolio Evaluation 288
8.9.3 Company SWOT Analysis 289
8.10 Medtronic 292
8.10.1 Overview 292
8.10.2 Portfolio Evaluation 293
8.10.3 Company SWOT Analysis 296
8.11 MicroPort Scientific Company 300
8.11.1 Overview 300
8.11.2 Portfolio Evaluation 300
8.11.3 MicroPort Scientific SWOT Analysis 301
8.12 St. Jude Medical 304
8.12.1 Overview 304
8.12.2 Portfolio Evaluation 304
8.12.3 Company SWOT Analysis 307
8.13 Stereotaxis 310
8.13.1 Overview 310
8.13.2 Portfolio Evaluation 310
8.13.3 Commercial Positioning 311
8.13.4 Company SWOT Analysis 312
8.14 Stryker Sustainability Solutions 319
8.14.1 Overview 319
8.14.2 Portfolio Evaluation 319
8.14.3 Company SWOT Analysis 320
8.15 Topera Medical 323
8.15.1 Overview 323
8.15.2 Portfolio Evaluation 323
8.15.3 Company SWOT Analysis 324
9 Pipeline Product Assessment 327
9.1 Pipeline Assessment by Development Stage 327
9.2 Segment Analysis of Pipeline Products 328
9.2.1 Ablation Catheter Pipeline Products 328
9.2.2 Diagnostic Catheter Pipeline Products 335
9.3 Lab Systems 336
9.3.1 Integrated X-Ray and Robotic Catheter System (Hansen Medical, Philips Healthcare) 336
9.3.2 ClearTrace System (MRI Interventions) 336
9.3.3 Robotic Catheter Guidance Lab System (North Carolina State University) 337
9.3.4 Catheter Guidance Lab System (SCR) 338
10 Strategic Deals Analysis 339
10.1 Key Acquisitions 339
10.1.1 Boston Scientific Acquires C.R. Bard's Electrophysiology Business for $275m 339
10.1.2 St. Jude Medical Acquires Endosense for $161m 339
10.1.3 Boston Scientific Acquires Rhythmia Medical for $265m 340
10.2 Key Partnerships 340
10.2.1 Philips and Biosense Webster Technology Integration Agreement 340
10.2.2 Biosense Webster Technology Integration Agreement with GE Healthcare Systems and Siemens Healthcare 340
10.2.3 Abbott and St. Jude Medical Broaden Alliance in US Cardiovascular Device Market 341
11 Appendix 342
11.1 Bibliography 342
11.2 Abbreviations 353
11.3 Report Methodology 358
11.3.1 Overview 358
11.3.2 Coverage 358
11.3.3 Secondary Research 358
11.3.4 Forecasting Methodology 359
11.3.5 Primary Research - Key Opinion Leader Interviews 360
11.3.6 Expert Panel Validation 361
11.4 Physicians Included in this Study 362
11.5 About the Authors 365
11.5.1 Analysts 365
11.5.2 Global Head of Healthcare 366
11.6 About MediPoint 367
11.7 About GlobalData 367
11.8 Disclaimer 367

List of Tables

Table 1: New York Heart Association Scale 41
Table 2: American College of Cardiology Scale 41
Table 3: Prevalent Cases of Congestive Heart Failure, Nine Major Markets, Ages ?45 Years, Men and Women (N), 2012-2019 45
Table 4: Atrial Fibrillation Treatment Goals 47
Table 5: Reasons for Lack of Consensus on Site for Ablation 52
Table 6: Techniques for Treatment of Persistent and Permanent Atrial Fibrillation 53
Table 7: Types of Atrial Fibrillation based of Triggers 55
Table 8: Characteristics of Catheter Ablation by Arrhythmia Type (%) 57
Table 9: Rates of Occurrence of Major Complications with Catheter Ablation (%), 2003-2006 58
Table 10: Catheter Ablation Success for the Treatment of Atrial Fibrillation (%), Global, 1995-2002 & 2003-2006 59
Table 11: Catheter Ablation Success by Arrhythmia Type (%), 2009 60
Table 12: Classes of Recommendations 61
Table 13: Level of Evidence 61
Table 14: Estimation of Total Incremental Health Care Costs in Patients with Atrial Fibrillation ($), US, 2008 67
Table 15: Complications Associated with Atrial Fibrillation and Their Incremental Medicare Costs, US, 2008 69
Table 16: Average Selling Price of Electrophysiology Products by Type, Global, 2013 70
Table 17: Percentage of Population Age 65 and Older, by Country, 2010-2015 82
Table 18: Overview of the Applications, Benefits, Limitations, and Future Directions of Remote Navigation Systems in Electrophysiology 86
Table 19: Key Acquisitions in the Electrophysiology Devices Market 89
Table 20: Advantages and Disadvantages of Various Energy Sources Used for Catheter Ablation 100
Table 21: Experimental Theories of How Atrial Fibrillation Perpetuates 108
Table 22: Antiarrhythmic Drug Classification by Mode of Action 111
Table 23: Major Complications Associated with Catheter Ablation 115
Table 24: Complications Associated with Catheter Ablation 115
Table 25: Recently Approved and Investigational Antiarrhythmic Drugs Under Development 117
Table 26: Ablation Catheters Market, Global, Historic Revenue ($m), 2005-2013 130
Table 27: Ablation Catheters Market, Global, Forecast Revenue ($m), 2013-2020 131
Table 28: Diagnostic Catheters Market, Global, Historic Revenue ($m), 2005-2013 132
Table 29: Diagnostic Catheters Market, Global, Forecast Revenue ($m), 2013-2020 133
Table 30: Lab Systems Market, Global, Historic Revenue ($m), 2005-2013 134
Table 31: Lab Systems Market, Global, Forecast Revenue ($m), 2013-2020 135
Table 32: Diagnosed Patient Volume by Disease Type, Diagnosed Patients (N), US, 2013 138
Table 33: Ablation Catheters Market, US, Historic Revenue ($m), 2005-2013 139
Table 34: Ablation Catheters Market, US, Forecast Revenue ($m), 2013-2020 140
Table 35: Diagnostic Catheters Market, US, Historic Revenue ($m), 2005-2013 141
Table 36: Diagnostic Catheters Market, US, Forecast Revenue ($m), 2013-2020 142
Table 37: Lab Systems Market, US, Historic Revenue ($m), 2005-2013 143
Table 38: Lab Systems Market, US, Forecast Revenue ($m), 2013-2020 144
Table 39: Diagnosed Patient Volume by Disease Type, Diagnosed Patients (N), France, 2013 150
Table 40: Ablation Catheters Market, France, Historic Revenue ($m), 2005-2013 151
Table 41: Ablation Catheters Market, France, Forecast Revenue ($m), 2013-2020 152
Table 42: Diagnostic Catheters Market, France, Historic Revenue ($m), 2005-2013 153
Table 43: Diagnostic Catheters Market, France, Forecast Revenue ($m), 2013-2020 154
Table 44: Lab Systems Market, France, Historic Revenue ($m), 2005-2013 155
Table 45: Lab Systems Market, France, Forecast Revenue ($m), 2013-2020 156
Table 46: Diagnosed Patient Volume by Disease Type, Diagnosed Patients (N), Germany, 2013 159
Table 47: Ablation Catheters Market, Germany, Historic Revenue ($m), 2005-2013 160
Table 48: Ablation Catheters Market, Germany, Forecast Revenue ($m), 2013-2020 161
Table 49: Diagnostic Catheters Market, Germany, Historic Revenue ($m), 2005-2013 162
Table 50: Diagnostic Catheters Market, Germany, Forecast Revenue ($m), 2013-2020 163
Table 51: Lab Systems Market, Germany, Historic Revenue ($m), 2005-2013 164
Table 52: Lab Systems Market, Germany, Forecast Revenue ($m), 2013-2020 165
Table 53: Diagnosed Patient Volume by Disease Type, Diagnosed Patients (N), Italy, 2013 168
Table 54: Ablation Catheters Market, Italy, Historic Revenue ($m), 2005-2013 169
Table 55: Ablation Catheters Market, Italy, Forecast Revenue ($m), 2013-2020 170
Table 56: Diagnostic Catheters Market, Italy, Historic Revenue ($m), 2005-2013 171
Table 57: Diagnostic Catheters Market, Italy, Forecast Revenue ($m), 2013-2020 172
Table 58: Lab Systems Market, Italy, Historic Revenue ($m), 2005-2013 173
Table 59: Lab Systems Market, Italy, Forecast Revenue ($m), 2013-2020 174
Table 60: Diagnosed Patient Volume by Disease Type, Diagnosed Patients (N), Spain, 2013 181
Table 61: Ablation Catheters Market, Spain, Historic Revenue ($m), 2005-2013 182
Table 62: Ablation Catheters Market, Spain, Forecast Revenue ($m), 2013-2020 183
Table 63: Diagnostic Catheters Market, Spain, Historic Revenue ($m), 2005-2013 184
Table 64: Diagnostic Catheters Market, Spain, Forecast Revenue ($m), 2013-2020 185
Table 65: Lab Systems Market, Spain, Historic Revenue ($m), 2005-2013 186
Table 66: Lab Systems Market, Spain, Forecast Revenue ($m), 2013-2020 187
Table 67: Diagnosed Patient Volume by Disease Type, Diagnosed Patients (N), UK, 2013 190
Table 68: Ablation Catheters Market, UK, Historic Revenue ($m), 2005-2013 191
Table 69: Ablation Catheters Market, UK, Forecast Revenue ($m), 2013-2020 192
Table 70: Diagnostic Catheters Market, UK, Historic Revenue ($m), 2005-2013 193
Table 71: Diagnostic Catheters Market, UK, Forecast Revenue ($m), 2013-2020 194
Table 72: Lab Systems Market, UK, Historic Revenue ($m), 2005-2013 195
Table 73: Lab Systems Market, UK, Forecast Revenue ($m), 2013-2020 196
Table 74: Diagnosed Patient Volume by Disease Type, Diagnosed Patients (N), Japan, 2013 199
Table 75: Ablation Catheters Market, Japan, Historic Revenue ($m), 2005-2013 200
Table 76: Ablation Catheters Market, Japan, Forecast Revenue ($m), 2013-2020 201
Table 77: Diagnostic Catheters Market, Japan, Historic Revenue ($m), 2005-2013 202
Table 78: Diagnostic Catheters Market, Japan, Forecast Revenue ($m), 2013-2020 203
Table 79: Lab Systems Market, Japan, Historic Revenue ($m), 2005-2013 204
Table 80: Lab Systems Market, Japan, Forecast Revenue ($m), 2013-2020 205
Table 81: Diagnosed Patient Volume by Disease Type, Diagnosed Patients (N), China, 2013 209
Table 82: Ablation Catheters Market, China, Historic Revenue ($m), 2005-2013 210
Table 83: Ablation Catheters Market, China, Forecast Revenue ($m), 2013-2020 210
Table 84: Diagnostic Catheters Market, China, Historic Revenue ($m), 2005-2013 211
Table 85: Diagnostic Catheters Market, China, Forecast Revenue ($m), 2013-2020 212
Table 86: Lab Systems Market, China, Historic Revenue ($m), 2005-2013 213
Table 87: Lab Systems Market, China, Forecast Revenue ($m), 2013-2020 214
Table 88: Diagnosed Patient Volume by Disease Type, Diagnosed Patients (N), India, 2013 218
Table 89: Ablation Catheters Market, India, Historic Revenue ($m), 2005-2013 219
Table 90: Ablation Catheters Market, India, Forecast Revenue ($m), 2013-2020 220
Table 91: Diagnostic Catheters Market, India, Historic Revenue ($m), 2005-2013 221
Table 92: Diagnostic Catheters Market, India, Forecast Revenue ($m), 2013-2020 221
Table 93: Lab Systems Market, India, Historic Revenue ($m), 2005-2013 222
Table 94: Lab Systems Market, India, Forecast Revenue ($m), 2013-2020 223
Table 95: Diagnosed Patient Volume by Disease Type, Diagnosed Patients (N), Brazil, 2013 228
Table 96: Ablation Catheters Market, Brazil, Historic Revenue ($m), 2005-2013 229
Table 97: Ablation Catheters Market, Brazil, Forecast Revenue ($m), 2013-2020 229
Table 98: Diagnostic Catheters Market, Brazil, Historic Revenue ($m), 2005-2013 230
Table 99: Diagnostic Catheters Market, Brazil, Forecast Revenue ($m), 2013-2020 231
Table 100: Lab Systems Market, Brazil, Historic Revenue ($m), 2005-2013 232
Table 101: Lab Systems Market, Brazil, Forecast Revenue ($m), 2013-2020 233
Table 102: Company Share, US, Total Electrophysiology Market Revenue (%), 2012 237
Table 103: Company Share, France, Total Electrophysiology Market Revenue (%), 2012 238
Table 104: Company Share, Germany, Total Electrophysiology Market Revenue (%), 2012 239
Table 105: Company Share, Italy, Total Electrophysiology Market Revenue (%), 2012 240
Table 106: Company Share, Spain, Total Electrophysiology Market Revenue (%), 2012 241
Table 107: Company Share, UK, Total Electrophysiology Market Revenue (%), 2012 242
Table 108: Company Share, Japan, Total Electrophysiology Market Revenue (%), 2012 243
Table 109: Company Share, China, Total Electrophysiology Market Revenue (%), 2012 244
Table 110: Company Share, India, Total Electrophysiology Market Revenue (%), 2012 245
Table 111: Company Share, Brazil, Total Electrophysiology Market Revenue (%), 2012 246
Table 112: Company Profile - Biosense Webster 248
Table 113: Biosense Webster, Electrophysiology Devices Portfolio 249
Table 114: SWOT Analysis - Biosense Webster 249
Table 115: Company Profile - Biotronik 253
Table 116: Biotronik, Electrophysiology Devices Portfolio 254
Table 117: SWOT Analysis - Biotronik 254
Table 118: Company Profile - Boston Scientific 260
Table 119: Boston Scientific, Electrophysiology Devices Portfolio 262
Table 120: SWOT Analysis - Boston Scientific 263
Table 121: Company Profile - CardioFocus 270
Table 122: CardioFocus, Electrophysiology Devices Portfolio 271
Table 123: SWOT Analysis - CardioFocus 271
Table 124: Company Profile - CardioInsight 274
Table 125: CardioInsight, Electrophysiology Devices Portfolio 274
Table 126: SWOT Analysis - CardioInsight 275
Table 127: Company Profile - Hansen Medical 277
Table 128: Hansen Medical, Electrophysiology Devices Portfolio 278
Table 129: SWOT Analysis - Hansen Medical 278
Table 130: Company Profile - Imricor 281
Table 131: SWOT Analysis - Imricor 282
Table 132: Company Profile - Japan Lifeline 285
Table 133: Japan Lifeline, Electrophysiology Devices Portfolio 285
Table 134: SWOT Analysis - Japan Lifeline 285
Table 135: Company Profile - Magnetecs Corporation 288
Table 136: Magnetecs Corporation, Electrophysiology Devices Portfolio 289
Table 137: SWOT Analysis - Magnetecs Corporation 289
Table 138: Company Profile - Medtronic 292
Table 139: Medtronic, Electrophysiology Devices Portfolio, 2013 295
Table 140: SWOT Analysis - Medtronic 296
Table 141: Company Profile - MicroPort Scientific Company 300
Table 142: MicroPort Scientific, Electrophysiology Devices Portfolio 301
Table 143: SWOT Analysis - MicroPort Scientific 301
Table 144: Company Profile - St. Jude Medical 304
Table 145: St. Jude Medical, Electrophysiology Devices Portfolio 306
Table 146: SWOT Analysis - St. Jude Medical 307
Table 147: Company Profile - Stereotaxis 310
Table 148: Stereotaxis, Electrophysiology Devices Portfolio 312
Table 149: SWOT Analysis - Stereotaxis 313
Table 150: Company Profile - Stryker Sustainability Solutions 319
Table 151: Stryker Sustainability Solutions, Electrophysiology Devices Portfolio 320
Table 152: SWOT Analysis - Stryker Sustainability Solutions 320
Table 153: Company Profile - Topera Medical 323
Table 154: Topera Medical, Electrophysiology Devices Portfolio, 2013 324
Table 155: SWOT Analysis - Topera Medical 324
Table 156: Ablation Catheter Pipeline Products 327
Table 157: Diagnostic Catheter Pipeline Products 327
Table 158: Lab Systems Pipeline Products 327
Table 159: Catheter Ablation Device, Product Status 328
Table 160: Ablation Catheter Device - Transcutaneous Monitoring to Avoid Hypercapnea during Complex Catheter Ablations 329
Table 161: Apama Medical Ablation Catheter, Product Status 330
Table 162: Cooled Tip Catheter, Product Status 330
Table 163: MaPP-CS, Product Status 331
Table 164: ROF-AC, Product Status 331
Table 165: ROF-AS, Product Status 332
Table 166: Vision MR Ablation Catheter, Product Status 332
Table 167: Voyager Irrigated RFA Catheter, Product Status 333
Table 168: Navigation and Ablation Catheter, Product Status 333
Table 169: Hot Balloon Catheter, Product Status 334
Table 170: Lesion Assessment Device, Product Status 335
Table 171: Horizon MR Recording System, Product Status 335
Table 172: Integrated X-Ray and Robotic Catheter System, Product Status 336
Table 173: ClearTrace System, Product Status 337
Table 174: Robotic Catheter Guidance Lab System, Product Status 337
Table 175: Catheter Guidance Lab System, Product Status 338
Table 176: Key Acquisitions in the Electrophysiology Market 339

1.2 List of Figures
Figure 1: Types of Arrhythmia 33
Figure 2: Pulmonary Vein Ablation Procedure 49
Figure 3: Antiarrhythmic Drugs and/or Ablation for Rhythm Control in Atrial Fibrillation 62
Figure 4: Cost Comparison of Ablation versus Antiarrhythmic Drug Therapy, 2009 64
Figure 5: Breakdown of National Incremental Costs in patients with Atrial Fibrillation 68
Figure 6: Ablation Catheters Market, Global, Historic Revenue ($m), 2005-2013 130
Figure 7: Ablation Catheters Market, Global, Forecast Revenue ($m), 2013-2020 131
Figure 8: Diagnostic Catheters Market, Global, Historic Revenue ($m), 2005-2013 132
Figure 9: Diagnostic Catheters Market, Global, Forecast Revenue ($m), 2013-2020 133
Figure 10: Lab Systems Market, Global, Historic Revenue ($m), 2005-2013 134
Figure 11: Lab Systems Market, Global, Forecast Revenue ($m), 2013-2020 135
Figure 12: Diagnosed Patient Volume by Disease Type, Diagnosed Patients (%), US, 2013 138
Figure 13: Ablation Catheters Market, US, Historic Revenue ($m), 2005-2013 139
Figure 14: Ablation Catheters Market, US, Forecast Revenue ($m), 2013-2020 140
Figure 15: Diagnostic Catheters Market, US, Historic Revenue ($m), 2005-2013 141
Figure 16: Diagnostic Catheters Market, US, Forecast Revenue ($m), 2013-2020 142
Figure 17: Lab Systems Market, US, Historic Revenue ($m), 2005-2013 143
Figure 18: Lab Systems Market, US, Forecast Revenue ($m), 2013-2020 144
Figure 19: Diagnosed Patient Volume by Disease Type, Diagnosed Patients (%), France, 2013 150
Figure 20: Ablation Catheters Market, France, Historic Revenue ($m), 2005-2013 151
Figure 21: Ablation Catheters Market, France, Forecast Revenue ($m), 2013-2020 152
Figure 22: Diagnostic Catheters Market, France, Historic Revenue ($m), 2005-2013 153
Figure 23: Diagnostic Catheters Market, France, Forecast Revenue ($m), 2013-2020 154
Figure 24: Lab Systems Market, France, Historic Revenue ($m), 2005-2013 155
Figure 25: Lab Systems Market, France, Forecast Revenue ($m), 2013-2020 156
Figure 26: Diagnosed Patient Volume by Disease Type, Diagnosed Patients (%), Germany, 2013 159
Figure 27: Ablation Catheters Market, Germany, Historic Revenue ($m), 2005-2013 160
Figure 28: Ablation Catheters Market, Germany, Forecast Revenue ($m), 2013-2020 161
Figure 29: Diagnostic Catheters Market, Germany, Historic Revenue ($m), 2005-2013 162
Figure 30: Diagnostic Catheters Market, Germany, Forecast Revenue ($m), 2013-2020 163
Figure 31: Lab Systems Market, Germany, Historic Revenue ($m), 2005-2013 164
Figure 32: Lab Systems Market, Germany, Forecast Revenue ($m), 2013-2020 165
Figure 33: Diagnosed Patient Volume by Disease Type, Diagnosed Patients (%), Italy, 2013 168
Figure 34: Ablation Catheters Market, Italy, Historic Revenue ($m), 2005-2013 169
Figure 35: Ablation Catheters Market, Italy, Forecast Revenue ($m), 2013-2020 170
Figure 36: Diagnostic Catheters Market, Italy, Historic Revenue ($m), 2005-2013 171
Figure 37: Diagnostic Catheters Market, Italy, Forecast Revenue ($m), 2013-2020 172
Figure 38: Lab Systems Market, Italy, Historic Revenue ($m), 2005-2013 173
Figure 39: Lab Systems Market, Italy, Forecast Revenue ($m), 2013-2020 174
Figure 40: Ablating Centers in Spain, 2001-2011 175
Figure 41: Ablation Procedures by Hospital Size and Type, 2012 176
Figure 42: Ablation Procedures by Target Substrate 177
Figure 43: Diagnosed Patient Volume by Disease Type, Diagnosed Patients (%), Spain, 2013 182
Figure 44: Ablation Catheters Market, Spain, Historic Revenue ($m), 2005-2013 183
Figure 45: Ablation Catheters Market, Spain, Forecast Revenue ($m), 2013-2020 184
Figure 46: Diagnostic Catheters Market, Spain, Historic Revenue ($m), 2005-2013 185
Figure 47: Diagnostic Catheters Market, Spain, Forecast Revenue ($m), 2013-2020 186
Figure 48: Lab Systems Market, Spain, Historic Revenue ($m), 2005-2013 187
Figure 49: Lab Systems Market, Spain, Forecast Revenue ($m), 2013-2020 188
Figure 50: Diagnosed Patient Volume by Disease Type, Diagnosed Patients (%), UK, 2013 191
Figure 51: Ablation Catheters Market, UK, Historic Revenue ($m), 2005-2013 192
Figure 52: Ablation Catheters Market, UK, Forecast Revenue ($m), 2013-2020 193
Figure 53: Diagnostic Catheters Market, UK, Historic Revenue ($m), 2005-2013 194
Figure 54: Diagnostic Catheters Market, UK, Forecast Revenue ($m), 2013-2020 195
Figure 55: Lab Systems Market, UK, Historic Revenue ($m), 2005-2013 196
Figure 56: Lab Systems Market, UK, Forecast Revenue ($m), 2013-2020 197
Figure 57: Diagnosed Patient Volume by Disease Type, Diagnosed Patients (%), Japan, 2013 200
Figure 58: Ablation Catheters Market, Japan, Historic Revenue ($m), 2005-2013 201
Figure 59: Ablation Catheters Market, Japan, Forecast Revenue ($m), 2013-2020 202
Figure 60: Diagnostic Catheters Market, Japan, Historic Revenue ($m), 2005-2013 203
Figure 61: Diagnostic Catheters Market, Japan, Forecast Revenue ($m), 2013-2020 204
Figure 62: Lab Systems Market, Japan, Historic Revenue ($m), 2005-2013 205
Figure 63: Lab Systems Market, Japan, Forecast Revenue ($m), 2013-2020 206
Figure 64: Diagnosed Patient Volume by Disease Type, Diagnosed Patients (%), China, 2013 209
Figure 65: Ablation Catheters Market, China, Historic Revenue ($m), 2005-2013 210
Figure 66: Ablation Catheters Market, China, Forecast Revenue ($m), 2013-2020 211
Figure 67: Diagnostic Catheters Market, China, Historic Revenue ($m), 2005-2013 212
Figure 68: Diagnostic Catheters Market, China, Forecast Revenue ($m), 2013-2020 213
Figure 69: Lab Systems Market, China, Historic Revenue ($m), 2005-2013 214
Figure 70: Lab Systems Market, China, Forecast Revenue ($m), 2013-2020 215
Figure 71: Diagnosed Patient Volume by Disease Type, Diagnosed Patients (%), India, 2013 218
Figure 72: Ablation Catheters Market, India, Historic Revenue ($m), 2005-2013 219
Figure 73: Ablation Catheters Market, India, Forecast Revenue ($m), 2013-2020 220
Figure 74: Diagnostic Catheters Market, India, Historic Revenue ($m), 2005-2013 221
Figure 75: Diagnostic Catheters Market, India, Forecast Revenue ($m), 2013-2020 222
Figure 76: Lab Systems Market, India, Historic Revenue ($m), 2005-2013 223
Figure 77: Lab Systems Market, India, Forecast Revenue ($m), 2013-2020 224
Figure 78: Diagnosed Patient Volume by Disease Type, Diagnosed Patients (%), Brazil, 2013 228
Figure 79: Ablation Catheters Market, Brazil, Historic Revenue ($m), 2005-2013 229
Figure 80: Ablation Catheters Market, Brazil, Forecast Revenue ($m), 2013-2020 230
Figure 81: Diagnostic Catheters Market, Brazil, Historic Revenue ($m), 2005-2013 231
Figure 82: Diagnostic Catheters Market, Brazil, Forecast Revenue ($m), 2013-2020 232
Figure 83: Lab Systems Market, Brazil, Historic Revenue ($m), 2005-2013 233
Figure 84: Lab Systems Market, Brazil, Forecast Revenue ($m), 2013-2020 234
Figure 85: Company Share, US, Total Electrophysiology Market Revenue (%), 2012 237
Figure 86: Company Share, France, Total Electrophysiology Market Revenue (%), 2012 239
Figure 87: Company Share, Germany, Total Electrophysiology Market Revenue (%), 2012 240
Figure 88: Company Share, Italy, Total Electrophysiology Market Revenue (%), 2012 241
Figure 89: Company Share, Spain, Total Electrophysiology Market Revenue (%), 2012 242
Figure 90: Company Share, UK, Total Electrophysiology Market Revenue (%), 2012 243
Figure 91: Company Share, Japan, Total Electrophysiology Market Revenue (%), 2012 244
Figure 92: Company Share, China, Total Electrophysiology Market Revenue (%), 2012 245
Figure 93: Company Share, India, Total Electrophysiology Market Revenue (%), 2012 246
Figure 94: Company Share, Brazil, Total Electrophysiology Market Revenue (%), 2012 247

Companies Mentioned

Biosense Webster
Biotronik
Boston Scientific
CardioFocus
CardioInsight
Hansen Medical
Imricor
Japan Lifeline
Magnetecs Corporation
Medtronic
MicroPort Scientific Company
St. Jude Medical
Stereotaxis
Stryker Sustainability Solutions
Topera Medical

Read the full report:
MediPoint: Electrophysiology - Global Analysis and Market Forecasts

http://www.reportbuyer.com/pharma_healthcare/medical_devices/medipoint_electrophysiology_global_analysis_market_forecasts.html

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com  
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow